| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/20/1997 | WO1997010229A1 Novel n-aminoalkylfluorenecarboxamides; a new class of dopamine receptor subtype specific ligands |
| 03/20/1997 | WO1997010223A1 Aminoaryl oxazolidinone n-oxides |
| 03/20/1997 | WO1997010211A1 Novel human nk3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 03/20/1997 | WO1997010210A1 Tricyclic pyrrolidine derivatives as calcium channel antagonists |
| 03/20/1997 | WO1997010207A1 Novel benzamide derivatives |
| 03/20/1997 | WO1997010204A1 L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors |
| 03/20/1997 | WO1997010006A1 Method for inhibiting cell-mediated killing of target cells |
| 03/20/1997 | WO1997009998A2 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 03/20/1997 | WO1997009995A1 Method for reducing the severity of gastro-intestinal damage |
| 03/20/1997 | WO1997009989A1 Compositions with anti-apoptotic activity, containing a mixture of phospholipids |
| 03/20/1997 | WO1997009987A1 Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids |
| 03/20/1997 | WO1997009981A1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 03/20/1997 | WO1997009977A1 Specific cyclooxygenase 2 inhibitor and anti-inflammatory agent |
| 03/20/1997 | WO1997009973A2 Peripherally active anti-hyperalgesic opiates |
| 03/20/1997 | WO1997000892A3 Depigmenting activity of agouti signal protein and peptides thereof |
| 03/20/1997 | CA2356097A1 Peripherally active anti-hyperalgesic opiates |
| 03/20/1997 | CA2232161A1 Diarylalkenylamine derivatives |
| 03/20/1997 | CA2232007A1 1-acyl-3-phenyl-3-(3-piperidinopropyl)piperidine derivatives as human nk3 receptor selective antagonists |
| 03/20/1997 | CA2232000A1 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
| 03/20/1997 | CA2231804A1 Method for inhibiting cell-mediated killing of target cells |
| 03/20/1997 | CA2231768A1 L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors |
| 03/20/1997 | CA2231433A1 Method for modulating cell apoptosis |
| 03/20/1997 | CA2231164A1 Esters of non-steroidal anti-inflammatory carboxylic acids |
| 03/20/1997 | CA2230970A1 Specific cyclooxygenase 2 inhibitor and anti-inflammatory agent |
| 03/20/1997 | CA2229435A1 Compositions with anti-apoptotic activity, containing a mixture of phospholipids |
| 03/20/1997 | CA2205056A1 Method for reducing the severity of gastro-intestinal damage |
| 03/20/1997 | CA2204002A1 Phenylsubstituted 4-azasteroid fluoroderivatives |
| 03/19/1997 | EP0763597A2 Use of cytohesin-PH peptides to influence the adhesion capability of integrins |
| 03/19/1997 | EP0763541A1 11-(Substituted phenyl)-estra-4,9-diene derivatives |
| 03/19/1997 | EP0763536A1 Process for producing 6-aminomethyl-substituted quinoline-benzoic acids |
| 03/19/1997 | EP0763534A1 Arylalkyl-diazinone derivatives as phosphodiesterase IV inhibitors |
| 03/19/1997 | EP0763527A1 Substituted 2,2-dimethyl-omega-phenoxy alkanoic acids and esters, process for their preparation and pharmaceutical compositions containing them |
| 03/19/1997 | EP0763120A1 Safe vectors for gene therapy |
| 03/19/1997 | EP0763055A1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same |
| 03/19/1997 | EP0763053A1 Steroid derivatives for treatment of 5 alpha reductase |
| 03/19/1997 | EP0763052A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
| 03/19/1997 | EP0763045A1 Haemopoietic maturation factor |
| 03/19/1997 | EP0763037A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 03/19/1997 | EP0763036A1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
| 03/19/1997 | EP0763034A1 Amide derivatives having 5ht1d-antagonist activity |
| 03/19/1997 | EP0763033A1 Imidazole derivatives and processes for the preparation thereof |
| 03/19/1997 | EP0763032A1 Palladium catalyzed ring closure of triazolyl tryptamine |
| 03/19/1997 | EP0763031A1 Piperazine derivatives as 5ht1a antagonists |
| 03/19/1997 | EP0763026A1 Gastrin and cck antagonists |
| 03/19/1997 | EP0763017A1 N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors |
| 03/19/1997 | EP0763016A1 Compositions and methods for treating mast-cell mediated conditions |
| 03/19/1997 | EP0763013A1 Hydroxylamine derivatives and their use as metalloproteinase inhibiting agents |
| 03/19/1997 | EP0763012A1 Succinyl hydroxamic acid, n-formyl-n-hydroxy amino carboxylic acid and succinic acid amide derivatives as metalloprotease inhibitors |
| 03/19/1997 | EP0762888A1 Copolymer-1 improvements in compositions of copolymers |
| 03/19/1997 | EP0762887A1 Acylated enol derivatives as prodrugs of elastase inhibitors |
| 03/19/1997 | EP0762886A1 Icam-1/lfa-1 short-chain peptides and method of using same |
| 03/19/1997 | EP0762883A1 Pyridylbisphosphonates for use as a therapeutical agent |
| 03/19/1997 | EP0762882A1 Vitronectin receptor antagonists |
| 03/19/1997 | EP0762880A1 Retroviral protease inhibitor combinations |
| 03/19/1997 | EP0762879A1 Stereochemical wortmannin derivatives |
| 03/19/1997 | EP0762877A1 Meta substituted arylalkylamines and therapeutic and diagnostic uses thereof |
| 03/19/1997 | EP0762876A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof |
| 03/19/1997 | EP0751948A4 Novel phosphoramidate and phophorothioamidate oligomeric compounds |
| 03/19/1997 | EP0667770B1 Inhibition of tnf production |
| 03/19/1997 | EP0644872B1 Ornithine decarboxylase inhibiting cyclic aminooxy compounds |
| 03/19/1997 | EP0634998B1 Hydroxamic acid based collagenase and cytokine inhibitors |
| 03/19/1997 | EP0624087B1 Spray-chilled nabumetone |
| 03/19/1997 | EP0607373B1 Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors |
| 03/19/1997 | EP0561965A4 Enhancement of musculature in animals |
| 03/19/1997 | CN1145637A Alpha-1-antichymotrypsin analogues having elastase inhibitory activity |
| 03/19/1997 | CN1145636A Vascular endothelial growth factor 2 |
| 03/19/1997 | CN1145619A Substituted pyridine leukotriene B4 antagonists |
| 03/19/1997 | CN1145364A Heterocyclic compounds and their preparation and use |
| 03/19/1997 | CN1145360A Substituted benzyloxy carbonyl guanidine, its prepn. method, and application of the same as medicament and medicament containing the same |
| 03/19/1997 | CN1145248A Physiological balancing agent for livestock and fowls |
| 03/19/1997 | CN1145223A Endothelin receptor antagonists |
| 03/18/1997 | US5612373 Certain diacyl hydrazine derivatives |
| 03/18/1997 | US5612371 Enzyme inhibitors |
| 03/18/1997 | US5612360 Aromatic n-heterocyclic compounds as hypotensive agents with acid groups, sulfonylcarboxamides or tetrazole groups |
| 03/18/1997 | US5612359 Substituted biphenyl isoxazole sulfonamides |
| 03/18/1997 | US5612356 Retinoid antagonists |
| 03/18/1997 | US5612353 Anticoagulant |
| 03/18/1997 | US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms |
| 03/18/1997 | US5612337 Analgesic compounds for prodrugs |
| 03/18/1997 | US5612335 Anticoagulants; combating/preventing diseases where cell aggregates occur or cell-matrix interactions play a part |
| 03/18/1997 | US5612325 Antiinflammatory and immunomodulating effects |
| 03/18/1997 | US5612321 Antioxidant grafted polysaccharides |
| 03/18/1997 | US5612314 Nitrosylated neuropeptides |
| 03/18/1997 | US5612195 Recombinant production of a human interferon (IFN)-gamma antagonist cytokine |
| 03/18/1997 | US5612194 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 03/18/1997 | US5611793 Disinfecting or sterilization tissues of mouths or wounds by applying photosensitizers |
| 03/18/1997 | CA2076980C Method and product for promoting hair growth and treating skin conditions |
| 03/15/1997 | CA2185517A1 Use of cytohesin-ph peptides for influencing the ability of integrins to adhere |
| 03/13/1997 | WO1997009335A1 Substituted phosphinic compounds and their use as pharmaceuticals |
| 03/13/1997 | WO1997009306A1 Novel isothiourea derivatives |
| 03/13/1997 | WO1997009064A1 Use of muteins of wild-type cytokines as immunogens |
| 03/13/1997 | WO1997009056A1 Extract of iridaceae and compositions containing such extract |
| 03/13/1997 | WO1997009052A1 Therapeutic azide compounds |
| 03/13/1997 | WO1997009051A1 Analogs for specific oligosaccharide-neuregulin interactions and uses thereof |
| 03/13/1997 | WO1997009043A1 Two-photon upconverting dyes and applications |
| 03/13/1997 | WO1997009040A1 2-alkylpyrrolidines |
| 03/13/1997 | WO1997009032A1 Utilization of an extract of a non photosynthetic filamentary bacterium and composition containing such extract |
| 03/13/1997 | WO1997008934A2 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors |
| 03/13/1997 | WO1996040784A3 Method of solubilizing, purifying, and refolding protein |
| 03/13/1997 | WO1996034964A3 Stable variant hk2 polypeptide |